Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12966)
All Articles published online
|
Publishing Process of This Article
|
Jun 18, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu SJ, Kim YJ. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World J Hepatol 2015; 7(11): 1553-1561 [PMID: 26085914 DOI: 10.4254/wjh.v7.i11.1553] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i11/1553.htm |
| Number | Citing Articles |
| 1 |
Wenzhe Fan, Guosheng Yuan, Huishuang Fan, Fuliang Li, Yanqin Wu, Yue Zhao, Wang Yao, Yu Wang, Miao Xue, Jianyong Yang, Jiaping Li. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Clinical Therapeutics 2019; 41(8): 1463 doi: 10.1016/j.clinthera.2019.04.036
|
| 2 |
Semih Hot, Metin Yeşiltaş, Berk Gökçek, Seracettin Eğin, Selma Şengiz. Massive and life-threatening upper gastrointestinal bleeding due to invasive hepatocellular carcinoma: A case report. International Journal of Surgery Case Reports 2016; 26: 69 doi: 10.1016/j.ijscr.2016.06.045
|
| 3 |
Jeong Won Lee, Sang Hyun Hwang, Do Young Kim, Kwang-Hyub Han, Mijin Yun. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma. Clinical Nuclear Medicine 2017; 42(1): e35 doi: 10.1097/RLU.0000000000001422
|
| 4 |
Hoon Sik Choi, Ki Mun Kang, Bae Kwon Jeong, Hojin Jeong, Yun Hee Lee, In Bong Ha, Jin Ho Song. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease. Asia-Pacific Journal of Clinical Oncology 2021; 17(3): 209 doi: 10.1111/ajco.13361
|
| 5 |
Xin Yang, Ying Zhu, Xia Zhao, Jian-hua Li, Da Xu, Hu-Liang Jia, Ju-bo Zhang. <p>The Prognostic Comparison Between Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and Bile Duct Cancer Thrombus After Liver Resection</p>. Cancer Management and Research 2020; : 12077 doi: 10.2147/CMAR.S278777
|
| 6 |
Biao Yang, Chun-Lin Li, Wen-hao Guo, Tian-qiang Qin, He Jiao, Ze-jun Fei, Xuan Zhou, Lin-jia Duan, Zheng-yin Liao. Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-3989-2
|
| 7 |
Zhi Dong, Yingyu Lin, Fangzeng Lin, Xuyi Luo, Zhi Lin, Yinhong Zhang, Lujie Li, Zi-Ping Li, Shi-Ting Feng, Huasong Cai, Zhenpeng Peng. Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography. Journal of Hepatocellular Carcinoma 2021; : 1473 doi: 10.2147/JHC.S334674
|
| 8 |
Mi Zhang, Xinyu Xiao, Liang Liu, Shanshan Liu, Haichuan Liu, Taojian Fan, Bin Zhang, Swelm Wageh, Ahmed Al-Ghamdi, Meijiao Wang, Jianwei Wang, Chengyou Du, Ning Jiang, Han Zhang, Qiling Peng. Aptamer‐Conjugated Biocompatible Nanospheres for Fluorescent Imaging–Guided Hepatocellular Carcinoma–Targeted Phototherapeutic Modality. Advanced NanoBiomed Research 2022; 2(9) doi: 10.1002/anbr.202200014
|
| 9 |
Raffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, Francesca Romana Ponziani. Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(11): 785 doi: 10.1080/17425255.2023.2272598
|
| 10 |
Young Youn Cho, Minjong Lee, Hyo-Cheol Kim, Jin Wook Chung, Yun Hwan Kim, Geum-Youn Gwak, Si Hyun Bae, Do Young Kim, Jeong Heo, Yoon Jun Kim, Matias A Avila. Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis. PLOS ONE 2016; 11(5): e0154986 doi: 10.1371/journal.pone.0154986
|
| 11 |
Pan He, Song Su, Cheng Fang, Kai He, Chongwei Chi, Xianming Xia, Jie Tian, Bo Li. Residual cancerous lesion and vein tumour thrombus identified intraoperatively using a fluorescence navigation system in liver surgery. ANZ Journal of Surgery 2019; 89(7-8) doi: 10.1111/ans.15282
|
| 12 |
Alberta Cappelli, Alessandro Cucchetti, Giuseppe Cabibbo, Cristina Mosconi, Marcello Maida, Simona Attardo, Irene Pettinari, Antonio D. Pinna, Rita Golfieri. Refining prognosis after trans‐arterial chemo‐embolization for hepatocellular carcinoma. Liver International 2016; 36(5): 729 doi: 10.1111/liv.13029
|
| 13 |
Jian Lu, Xiu-Ping Zhang, Bin-Yan Zhong, Wan Yee Lau, David C Madoff, Jon C Davidson, Xiaolong Qi, Shu-Qun Cheng, Gao-Jun Teng. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. The Lancet Gastroenterology & Hepatology 2019; 4(9): 721 doi: 10.1016/S2468-1253(19)30178-5
|
| 14 |
Gomathi Mohan, Ayisha Hamna T P, Jijo A J, Saradha Devi K M, Arul Narayanasamy, Balachandar Vellingiri. Recent advances in radiotherapy and its associated side effects in cancer—a review. The Journal of Basic and Applied Zoology 2019; 80(1) doi: 10.1186/s41936-019-0083-5
|
| 15 |
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
|
| 16 |
Bo Sun, Weihua Zhang, Lei Chen, Tao Sun, Yanqiao Ren, Licheng Zhu, Kun Qian, Chuansheng Zheng. The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus. Abdominal Radiology 2022; 47(2): 858 doi: 10.1007/s00261-021-03349-5
|
| 17 |
Min Zhang, Zhuangzhuang Zheng, Qiuhui Ding, Jing Su, Ying Xin, Xin Jiang. Radiotherapy plus lenvatinib versus radiotherapy plus sorafenib for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1458819
|
| 18 |
Sheng-Long Ye, Xiaoping Chen, Jiamei Yang, Ping Bie, Shuijun Zhang, Fengyong Liu, Luming Liu, Jie Zhou, Kefeng Dou, Christina SM Yip, Xiaolei Yang. Evaluation of sorafenib in Chinese unresectable hepatocellular carcinoma patients with prior surgery and portal vein tumor thrombosis: A subset analysis of GIDEON study data. Tumor Biology 2017; 39(3): 101042831769503 doi: 10.1177/1010428317695030
|
| 19 |
Qunfang Zhou, Yongcheng An, Ting Liu, Zishan Liu, Ruixia Li, Chenmeng Wang, Feng Zhou, Congjuan Liu, Kangshun Zhu. Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation. International Journal of Hyperthermia 2022; 39(1): 97 doi: 10.1080/02656736.2021.2021303
|
| 20 |
Wenchang Yu, Weifu Liu, Kongzhi Zhang, Shiguang Chen, Xiaolong Wang. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study. Cancer Immunology, Immunotherapy 2023; 72(11): 3609 doi: 10.1007/s00262-023-03511-6
|
| 21 |
Jin Y. Choi, Jeong I. Yu, Hee C. Park, C. H. David Kwon, Jong M. Kim, Jae‐Won Joh, Gyu‐Seong Choi, Jae B. Park, Sung J. Kim, Seung H. Lee, Won‐Tae Cho, Kyo W. Lee, Byeong‐Gon Na, Dong Kyu Oh, Nuri Lee, Chan W. Cho, Sanghoon Lee, Suk‐Koo Lee. The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus. Liver Transplantation 2017; 23(4): 545 doi: 10.1002/lt.24729
|
| 22 |
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew. Barcelona clinic liver cancer-stage C hepatocellular carcinoma. Medicine 2017; 96(17): e6745 doi: 10.1097/MD.0000000000006745
|
| 23 |
Leandro Cardarelli-Leite, John Chung, Darren Klass, Vladimir Marquez, Frank Chou, Stephen Ho, Henry Walton, Howard Lim, Peter Tae Wan Kim, Anastasia Hadjivassiliou, David M. Liu. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus. CardioVascular and Interventional Radiology 2020; 43(3): 411 doi: 10.1007/s00270-019-02404-5
|
| 24 |
Jungang Hu, Quan Bao, Guang Cao, Xu Zhu, Renjie Yang, Xinqiang Ji, Liang Xu, Kanglian Zheng, Weiliang Li, Baocai Xing, Xiaodong Wang. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis. CardioVascular and Interventional Radiology 2020; 43(7): 996 doi: 10.1007/s00270-019-02406-3
|
| 25 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for Paradigm Change in Management of Hepatocellular Carcinoma: Is a Personalized Approach on the Horizon?. Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
|
| 26 |
Shin Hwang, Deok-Bog Moon, Ki-Hun Kim, Chul-Soo Ahn, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Gastrointestinal Surgery 2021; 25(7): 1745 doi: 10.1007/s11605-020-04800-6
|
| 27 |
K. J. Hartrumpf, S. Marquardt, T. Werncke, T. Murray, M. M. Kirstein, A. Vogel, F. Wacker, T. Rodt. Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC. Journal of Cancer Research and Clinical Oncology 2018; 144(10): 1991 doi: 10.1007/s00432-018-2704-7
|
| 28 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 29 |
Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo. Sorafenib Treatment has the Potential to Downstage Advanced Hepatocellular Carcinoma before Liver Resection. Personalized Medicine 2020; 17(2): 83 doi: 10.2217/pme-2018-0114
|
| 30 |
Umberto Cillo, Alessandra Bertacco, Elisa Fasolo, Riccardo Carandina, Alessandro Vitale, Giacomo Zanus, Enrico Gringeri, Francesco D'Amico, Domenico Bassi, Daniele Neri, Vincenzo Dadduzio, Fabio Farinati, Camillo Aliberti. Videolaparoscopic microwave ablation in patients with HCC at a European high‐volume center: Results of 815 procedures. Journal of Surgical Oncology 2019; 120(6): 956 doi: 10.1002/jso.25651
|
| 31 |
Jan B. Hinrichs, Davut B. Hasdemir, Maximilian Nordlohne, Nora Schweitzer, Frank Wacker, Arndt Vogel, Martha M. Kirstein, Steffen Marquardt, Thomas Rodt. Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization. CardioVascular and Interventional Radiology 2017; 40(10): 1559 doi: 10.1007/s00270-017-1681-6
|
| 32 |
Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa, Amal M. El Gayar. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sciences 2019; 233: 116673 doi: 10.1016/j.lfs.2019.116673
|